Shafique Virani Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

RXRX Quotes by TradingView

Shafique Virani is Chief Business Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 136,748 shares of RXRX, which is worth approximately $970,910. The most recent transaction as insider was on Jan 16, 2024, when has been sold 18,000 shares (Class A Common Stock) at a price of $10.93 per share, resulting in proceeds of $196,740. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 137K
0% 3M change
2.57% 12M change
Total Value Held $970,910

Shafique Virani Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 16 2024
SELL
Open market or private sale
$196,740 $10.93 p/Share
18,000 Reduced 11.63%
136,748 Class A Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
$39,960 $2.22 p/Share
18,000 Added 10.42%
154,748 Class A Common Stock
Dec 15 2023
SELL
Open market or private sale
$172,800 $9.6 p/Share
18,000 Reduced 11.63%
136,748 Class A Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
$39,960 $2.22 p/Share
18,000 Added 10.42%
154,748 Class A Common Stock
Nov 15 2023
SELL
Open market or private sale
$117,180 $6.51 p/Share
18,000 Reduced 11.37%
140,351 Class A Common Stock
Nov 15 2023
SELL
Payment of exercise price or tax liability
$25,869 $7.18 p/Share
3,603 Reduced 2.57%
136,748 Class A Common Stock
Nov 15 2023
BUY
Exercise of conversion of derivative security
$39,960 $2.22 p/Share
18,000 Added 10.21%
158,351 Class A Common Stock
Oct 16 2023
SELL
Open market or private sale
$113,400 $6.3 p/Share
18,000 Reduced 11.37%
140,351 Class A Common Stock
Oct 16 2023
BUY
Exercise of conversion of derivative security
$39,960 $2.22 p/Share
18,000 Added 10.21%
158,351 Class A Common Stock
Sep 15 2023
SELL
Open market or private sale
$155,880 $8.66 p/Share
18,000 Reduced 11.37%
140,351 Class A Common Stock
Sep 15 2023
BUY
Exercise of conversion of derivative security
$39,960 $2.22 p/Share
18,000 Added 10.21%
158,351 Class A Common Stock
Aug 15 2023
SELL
Open market or private sale
$166,500 $9.25 p/Share
18,000 Reduced 11.37%
140,351 Class A Common Stock
Aug 15 2023
SELL
Payment of exercise price or tax liability
$33,111 $9.19 p/Share
3,603 Reduced 2.5%
140,351 Class A Common Stock
Aug 15 2023
BUY
Exercise of conversion of derivative security
$39,960 $2.22 p/Share
18,000 Added 10.21%
158,351 Class A Common Stock
Jul 26 2023
SELL
Open market or private sale
$288,200 $14.41 p/Share
20,000 Reduced 12.2%
143,954 Class A Common Stock
Jul 26 2023
BUY
Exercise of conversion of derivative security
$44,400 $2.22 p/Share
20,000 Added 10.87%
163,954 Class A Common Stock
Jul 25 2023
SELL
Open market or private sale
$286,000 $14.3 p/Share
20,000 Reduced 12.2%
143,954 Class A Common Stock
Jul 25 2023
BUY
Exercise of conversion of derivative security
$44,400 $2.22 p/Share
20,000 Added 10.87%
163,954 Class A Common Stock
Jul 18 2023
SELL
Open market or private sale
$412,200 $13.74 p/Share
30,000 Reduced 17.25%
143,954 Class A Common Stock
Jul 18 2023
BUY
Exercise of conversion of derivative security
$66,600 $2.22 p/Share
30,000 Added 14.71%
173,954 Class A Common Stock
Jul 17 2023
SELL
Open market or private sale
$351,600 $11.72 p/Share
30,000 Reduced 17.25%
143,954 Class A Common Stock
Jul 17 2023
BUY
Exercise of conversion of derivative security
$66,600 $2.22 p/Share
30,000 Added 14.71%
173,954 Class A Common Stock
Jun 16 2023
SELL
Open market or private sale
$282,300 $9.41 p/Share
30,000 Reduced 17.25%
143,954 Class A Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
$66,600 $2.22 p/Share
30,000 Added 14.71%
173,954 Class A Common Stock
Jun 15 2023
SELL
Open market or private sale
$290,100 $9.67 p/Share
30,000 Reduced 17.25%
143,954 Class A Common Stock
SV

Shafique Virani

Chief Business Officer
Salt Lake City, UT

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RXRX